The consultancy’s campaigns for Novartis in chronic
spontaneous urticaria are shortlisted in two categories: Excellence in Communications via Meetings and Excellence in the Communications of Survey or Market Research Data.
The Allergan “Migraine Unlocked” campaign is a finalist in Excellence in Communications via a Live
Event or Stand-Alone Activity, and an HCV programme for
AbbVie has been recognised in the Excellence
in Communications via Meetings category.
Carole North, managing director of 90TEN
said: “Being nominated for the Small
Consultancy of the Year Award and four client campaigns is a fantastic
acknowledgement of the success we achieved last year. The consolidation of our
behavioural change philosophy into our Life.Changing.
proposition has been welcomed not only by our clients but also embraced
internally by the 90TEN teams. It’s truly reflected in the work we deliver.”
Contact
Carole North, 90TEN –
carole.north@90ten.co.uk – +44(0)7970 863071
About 90TEN
90TEN is a global, independent healthcare
communications consultancy that delivers communications programmes which engage
people and change behaviours – helping to enhance clinical practice, increase
prescribing confidence and improve patient outcomes.